These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 26424649)

  • 21. Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection.
    Kasahara Y; Yachie A
    Crit Rev Oncol Hematol; 2002 Dec; 44(3):283-94. PubMed ID: 12467968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anything that can go wrong: cytotoxic cells and their control of Epstein-Barr virus].
    Gutiérrez-Guerrero A; Espinosa-Padilla SE; Lugo-Reyes SO
    Rev Alerg Mex; 2024 Feb; 71(1):29-39. PubMed ID: 38683066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural Killer cell transcriptome during primary EBV infection and EBV associated Hodgkin Lymphoma in children-A preliminary observation.
    M A; Chatterjee S; A P; S M; Davuluri S; Ar AK; T A; M P; Cs P; Sinha M; Chugani A; R VP; Kk A; R S J
    Immunobiology; 2020 May; 225(3):151907. PubMed ID: 32044149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
    Ohga S; Ishimura M; Yoshimoto G; Miyamoto T; Takada H; Tanaka T; Ohshima K; Ogawa Y; Imadome K; Abe Y; Akashi K; Hara T
    J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of NK Cells in EBV Infection and EBV-Associated NPC.
    Png YT; Yang AZY; Lee MY; Chua MJM; Lim CM
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33671917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection.
    Tsuge I; Morishima T; Kimura H; Kuzushima K; Matsuoka H
    J Med Virol; 2001 Jun; 64(2):141-8. PubMed ID: 11360246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-γ.
    Jud A; Kotur M; Berger C; Gysin C; Nadal D; Lünemann A
    Oncotarget; 2017 Jan; 8(4):6130-6141. PubMed ID: 28008151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle?
    Tatfi M; Hermine O; Suarez F
    Front Immunol; 2018; 9():3060. PubMed ID: 30662441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4+ T-lymphocyte-induced Epstein-Barr virus reactivation in a patient with severe hypersensitivity to mosquito bites and Epstein-Barr virus-infected NK cell lymphocytosis.
    Asada H; Miyagawa S; Sumikawa Y; Yamaguchi Y; Itami S; Suguri S; Harada M; Tokura Y; Ishihara S; Ohshima S; Yoshikawa K
    Arch Dermatol; 2003 Dec; 139(12):1601-7. PubMed ID: 14676078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic susceptibility to EBV infection: insights from inborn errors of immunity.
    Tangye SG
    Hum Genet; 2020 Jun; 139(6-7):885-901. PubMed ID: 32152698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.
    Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F
    Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic Defects in Phosphoinositide 3-Kinase δ Influence CD8
    Cannons JL; Preite S; Kapnick SM; Uzel G; Schwartzberg PL
    Front Immunol; 2018; 9():1758. PubMed ID: 30116245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary immunodeficiencies and the control of Epstein-Barr virus infection.
    Palendira U; Rickinson AB
    Ann N Y Acad Sci; 2015 Nov; 1356():22-44. PubMed ID: 26415106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening the PRF1, UNC13D, STX11, SH2D1A, XIAP, and ITK gene mutations in Chinese children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Zhizhuo H; Junmei X; Yuelin S; Qiang Q; Chunyan L; Zhengde X; Kunling S
    Pediatr Blood Cancer; 2012 Mar; 58(3):410-4. PubMed ID: 21674762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adoptive T Cell Therapy for Epstein-Barr Virus Complications in Patients With Primary Immunodeficiency Disorders.
    McLaughlin LP; Bollard CM; Keller MD
    Front Immunol; 2018; 9():556. PubMed ID: 29616044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chronic active Epstein-Barr virus infection].
    Kimura H
    Uirusu; 2011 Dec; 61(2):163-73. PubMed ID: 22916563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetics of Epstein-Barr virus infection.
    Hiraki A; Fujii N; Masuda K; Ikeda K; Tanimoto M
    Biomed Pharmacother; 2001 Sep; 55(7):369-72. PubMed ID: 11669499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
    Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N
    J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virological aspects of Epstein-Barr virus infections.
    Yamashita N; Kimura H; Morishima T
    Acta Med Okayama; 2005 Dec; 59(6):239-46. PubMed ID: 16418766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of human natural killer cells during Epstein-Barr virus infection.
    Münz C
    Crit Rev Immunol; 2014; 34(6):501-7. PubMed ID: 25597312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.